IP Intensive: A Semester at AstraZeneca Canada
Last semester, as part of Osgoode’s Intellectual Property Law and Technology Intensive Program, I had the opportunity to work with in-house counsel at AstraZeneca Canada.
Last semester, as part of Osgoode’s Intellectual Property Law and Technology Intensive Program, I had the opportunity to work with in-house counsel at AstraZeneca Canada.
The granting of a patent has often been described as a bargain [1] between the government and the patentee. In exchange for the exclusive right
In the past, Monsanto has been successful in defending the company’s patents concerning the genes and modified cells present in genetically modified (GM) plants in
What do cooking and chemistry have in common? Apparently, the former provides great analogies to explain the latter. Apotex has recently applied for judicial review
The government of Antigua and Barbuda has recently published a press release detailing their plans on establishing a statutory body to oversee the monetization and exploitation of the suspension
Where there’s smoke, there’s fire… or at least a heated debate. On October 8th, 2013, the European Parliament voted on the proposed revisions to the